Leap Therapeutics Inc (LPTX)
2.98
-0.02
(-0.50%)
USD |
NASDAQ |
Nov 14, 13:08
Leap Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Mar 2020
--
Maximum
Mar 2020
--
Average
--
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.4322 |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 0.7145 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 81.43M |
| Total Liabilities (Quarterly) | 15.64M |
| Shareholders Equity (Quarterly) | 65.79M |